European Journal of Medical and Health Research, Journal Year: 2024, Volume and Issue: 2(6), P. 44 - 57
Published: Nov. 1, 2024
Identification of new biomarkers in histopathology for better understanding disease diagnosis and outcome has received interest. Significant progresses have been achieved these fronts cancer through different tumors including Ki-67. Ki-67 is a biomarker that used to support its diagnostic prognostic cost showing potential diseases like gliomas, meningiomas, medulloblastomas, ependymomas. HER2 overexpressed the predictability breast cancer, while MSMB PSG2 are ideal prostate adenocarcinoma. Cancer dominated most study conducted within this field, therefore it important research go on apply clinical facilities enhancement prediction other diseases. It noteworthy directions, instance therapeutic response, reveal considerable rise comparison with indicators last year. Some require additional complex costly technology, but researchers agree discoveries practising should help clinicians make decision depending correct assessment patient’s state. Moreover, many still need confirming samples as examinations. Today, applied diagnostics based availability simple sweat, urine, blood, cerebrospinal fluid, saliva. increase use such since obtaining them easy, subject can be sampled little or no interferences at all terms invasiveness. The convenience not only increases willingness patient compliance process, also delivers far enhanced healthcare experience results. Therefore, presented earlier implementing together innovative state art techniques detection identification, process revolutionized. They possess remarkable features essential owing fact molecules cannot identified by routine modalities because structural molecular weight differences well highlighted. In words, provided first-of-its-kind approach recognising identifying evaluation analysis biomarkers. However, imperative strategies come related costs expenses order executed. relying mentioned considerations, mass spectrometry invariably recognized probably advisable definitely preferred option implement laboratories commercial medical facilities. Over implication somewhat high they offset advantages accuracy, sensitivity specificity technique. evolved critical asset use, which long run results prognosis precise therapy intercession. add ongoing upgrade technologies produce advances analysis, thus maintaining focus biomarker.
Language: Английский